Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk

Marco Valgimigli(University of Bern), Pieter C. Smits(Cardiovascular European Research Center), Felix Mahfoud(University of Basel), Antonio Colombo(Humanitas University), Andrés Íñiguez(University Hospital Complex Of Vigo), Mirvat Alasnag(King Fahd Armed Forces Hospital), Peter Jüni(University of Oxford), Jozef Bartúnek(University of Oxford), Peep Laanmets(North Estonia Medical Centre), Ran Kornowski(Tel Aviv University), Goran Stanković(University of Belgrade), Dik Heg, Stephan Windecker(University of Bern), Pascal Vranckx(Jessa Hospital), Marco Roffi(University of Geneva), Carl Schultz(The University of Western Australia), Sergio Leonardi(Policlinico San Matteo Fondazione), Bernard Chevalier(University of Zurich), David Hildick‐Smith(Sussex County Community College), Maciej Lesiak, Paul Jau Lueng Ong(Tan Tock Seng Hospital), Michael Donahue(Ente Ospedaliero Cantonale), Marie‐Claude Morice(Cardiovascular European Research Center), Jan G.P. Tijssen(Amsterdam UMC Location University of Amsterdam), Alfredo E. Rodríguez, Enrico Frigoli(University of Bern), Aris Moschovitis(University of Bern), Pim A.L. Tonino(Radboud University Nijmegen), Yukio Ozaki(Fujita Health University), Yoshinobu Onuma(Ollscoil na Gaillimhe – University of Galway)
New England Journal of Medicine
August 28, 2021
Cited by 571


Related Papers